TY - CHAP A1 - Derya Cayir A2 - Mine Araz ED1 - Cigdem Soydal Y1 - 2017-07-12 PY - 2017 T1 - Radioiodine Therapy of Malignant Thyroid Diseases N2 - This book has been designed to give a brief information on the development and current status of radionuclide treatments. Today, despite most of them have been accepted experimentally in the clinical guidelines, the number of the radionuclide treatments has been increasing gradually. Theranostic concept is the leading cause for this increase. Behind the radioiodine treatment for benign and malignant thyroid diseases, other radionuclide treatments that consist of I-131 metaiodobenzylguanidine therapy for neuroectodermal tumors, radionuclide pain palliation for bone metastases, radiosynovectomy, and selective internal radiation therapy were included in the book. All the chapters have been written by experienced nuclear medicine physicians. BT - Radionuclide Treatments SP - Ch. 2 UR - https://doi.org/10.5772/intechopen.68574 DO - 10.5772/intechopen.68574 SN - 978-953-51-3380-3 PB - IntechOpen CY - Rijeka Y2 - 2020-01-20 ER -